European equities traded in the US as American depositary receipts were down late Friday morning, falling 0.79% to 2,881.99 on the S&P Europe Select ADR Index, which was up 2% for the week.

From continental Europe, the gainers were led by biopharmaceutical firm DBV Technologies (DBVT) and pharmaceutical company Novo Nordisk (NVO), which advanced 12% and 4.8%, respectively. They were followed by petroleum refiner Equinor (EQNR) and biotech firm BioNTech (BNTX), which increased 2.4% and 2.2%, respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and pharmaceutical company Ascendis Pharma (ASND), which fell 7.1% and 3.3% respectively. They were followed by internet advertising firm Criteo (CRTO) and healthcare tech company Royal Philips (PHG), which were down 1.5% and 1.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Biodexa Pharmaceuticals (BDRX), which rose 1.7% and 1.4% respectively. They were followed by utilities company National Grid (NGG) and oil and gas company BP (BP), which were up 1% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which shed 9.7% and 4.5% respectively. They were followed by mining company BHP Group (BHP) and educational publisher Pearson (PSO), which dropped 2.5% each.